Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)	9 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Cash flows from operating activities
Net loss	$ (7,850,097)	$ (18,055,480)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation and amortization	1,883,391	2,033,752
Provision for losses on accounts receivable	7,122,447	16,970,555
Gain (Loss) on disposal of property, plant and equipment	67,750
Inventories impairment	2,248,187	3,969,293
Changes in operating assets
Digital assets	53,693	175,585
Accounts receivable	(13,056,367)	(15,259,021)
Amount due from related parties	(6,385)	27,787
Other current assets	(2,850,360)	199,768
Inventories	2,908,106	6,312,446
Advances to suppliers	(3,335,930)	(6,824,502)
Other assets	1,401,758	1,404,244
Deferred tax assets	(49,527)	(10,828)
Changes in operating liabilities
Accounts payable	(142,410)	(199,488)
Customer deposits	2,498,889	(335,612)
Amount due to related parties		(1,003)
Tax payables	(78,304)	(153,879)
Accrued expenses and other payables	1,844,050	2,430,107
Interest payable	1,141
Net cash used in operating activities	(7,339,968)	(7,316,276)
Cash flows from investing activities
Purchase of plant, property, and equipment	(245,364)	(1,651,010)
Long-term equity investment	(5,497,981)	(2,450,000)
Net cash used in investing activities	(5,743,345)	(4,101,010)
Cash flows from financing activities
Proceeds from loans	7,077,439	2,778,662
Repayment of loans	(3,845,409)	(1,639,410)
Other payable	99,117
Advance from related party	310,000	191,000
Repurchases of common stock	(398,526)
Net cash provided by financing activities	3,242,621	1,330,251
Effect of exchange rate change on cash and cash equivalents	(139,166)	540,604
Net decrease in cash and cash equivalents	(9,979,858)	(9,546,431)
Cash and cash equivalents, beginning balance	58,772,587	71,142,188
Cash and cash equivalents, ending balance	48,792,729	61,595,756
Supplement disclosure of cash flow information
Interest expense paid	346,833	216,828
Income taxes paid	$ 213,135	$ 193,833